Several contemporary formulations of hormone therapy administered during the menopausal transition carry some degree of cardiovascular risk, Swedish registry data affirm. Most consistent was an ...

Hormone therapies for menopause will no longer carry a black box warning about serious risks such as breast cancer, heart attack and stroke, the Food and Drug Administration announced Monday. In the ...

With the removal of FDA warning labels, hormone therapy to treat symptoms of menopause has grown in popularity. Now some patients are reporting delays in filling prescriptions for estrogen patches.

The warning label placed on all estrogen-based treatments since 2003 was based on an outdated and flawed government-funded ...

WASHINGTON -- Hormone-based drugs used to treat hot flashes and other menopause symptoms will no longer carry a bold warning label about stroke, heart attack, dementia and other serious risks, the ...

Menopausal hormone therapy (commonly known as hormone replacement therapy or HRT) is not associated with an increased risk of death, finds a Danish study of over 800,000 women published in The BMJ.

US health authorities are set Thursday to reassess Hormone Replacement Therapy (HRT), a treatment used by menopausal women around the world but long clouded by debate over its risks. HRT is taken to ...

Estrogen may help protect against hypertension in premenopause, a new study suggests, raising further questions about the role that hormone therapy may play in cardiovascular health later in life.

Hormone replacement therapy (HRT) has been shown to reduce bone loss in postmenopausal women, but there is limited research ...